Aptevo Therapeutics Inc. (APVO) Financial Statements (2023 and earlier)

Company Profile

Business Address 2401 4TH AVE.
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,63545,04439,97912,44830,63580,783
Cash and cash equivalents22,63545,04439,97912,44830,6357,095
Short-term investments      73,688
Restricted cash and investments  1,2592,555  400
Receivables  3,6642,3697,0225,2202,141
Inventory, net of allowances, customer advances and progress billings    6,1391,7851,028
Inventory    6,1391,7851,028
Prepaid expense1,5711,8232,2284,2266,907 
Other current assets7447801331604,1426,710
Other undisclosed current assets 2,500    4,022
Total current assets:27,45052,57047,26429,99548,68995,084
Noncurrent Assets
Operating lease, right-of-use asset5,3031,5842,7223,747
Property, plant and equipment1,4622,3792,8153,9465,2025,843
Intangible assets, net (including goodwill)    4,4205,2506,080
Intangible assets, net (excluding goodwill)    4,4205,2506,080
Restricted cash and investments    7,4987,44810,000
Other noncurrent assets  687463,802905 
Total noncurrent assets:6,7654,0316,28323,41318,80521,923
TOTAL ASSETS:34,21556,60153,54753,40867,494117,007
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,1052,0772,7573,5243,8984,626
Employee-related liabilities2,0772,7573,5243,8984,626
Accrued liabilities2,105     
Debt 2,00011,6675,00019,863 3,333
Other liabilities1,1022,0861,1991,0837963,201
Other undisclosed current liabilities3,49918,9275,58313,76912,9167,350
Total current liabilities:8,70634,75714,53938,23917,61018,510
Noncurrent Liabilities
Long-term debt and lease obligation 1,4565,04822,4143,32719,27815,728
Long-term debt, excluding current maturities 1,4563,70720,054 19,27815,728
Liabilities, other than long-term debt6,079   200734
Other liabilities     200734
Operating lease, liability6,0791,3412,3603,327
Other undisclosed noncurrent liabilities  14,239(2,360)   
Total noncurrent liabilities:7,53520,62822,4143,32719,47816,462
Total liabilities:16,24155,38536,95341,56637,08834,972
Equity
Equity, attributable to parent17,9741,21616,59411,84230,40682,035
Common stock484746452322
Additional paid in capital223,962215,232202,154179,653157,791155,837
Accumulated other comprehensive loss      (105)
Accumulated deficit(206,036)(214,063)(185,606)(167,856)(127,408)(73,719)
Total equity:17,9741,21616,59411,84230,40682,035
TOTAL LIABILITIES AND EQUITY:34,21556,60153,54753,40867,494117,007

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues12,50012,2924,30932,42423,06714,658
Revenue, net14,658
Revenue from related parties 12,500    
Cost of revenue
(Cost of Goods and Services Sold)
    (19,927) (5,010)
Gross profit:12,50012,2924,30912,49723,0679,648
Operating expenses(31,755)(33,692)(31,803)(55,093)(63,518)(63,597)
Other undisclosed operating loss(9,386)   (11,214) 
Operating loss:(28,641)(21,400)(27,494)(42,596)(51,665)(53,949)
Nonoperating income (expense)(1,527)(8,008)14,3382,148(2,024)(1,944)
Investment income, nonoperating2,500 14,3384,250  
Other nonoperating income (expense)(4,027)(8,008) (2,102)(2,024)(1,944)
Interest and debt expense 37,182 (2,105)(2)  
Income (loss) from continuing operations before equity method investments, income taxes:7,014(29,408)(15,261)(40,450)(53,689)(55,893)
Other undisclosed loss from continuing operations before income taxes   (15,662)(4,248)  
Income (loss) from continuing operations before income taxes:7,014(29,408)(30,923)(44,698)(53,689)(55,893)
Income tax benefit      23,301
Income (loss) from continuing operations:7,014(29,408)(30,923)(44,698)(53,689)(32,592)
Income (loss) before gain (loss) on sale of properties:(28,457)(17,750)(40,448)(53,689)6,973
Income from discontinued operations1,01395113,1734,250 39,565
Net income (loss) available to common stockholders, diluted:8,027(28,457)(17,750)(40,448)(53,689)6,973

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):8,027(28,457)(17,750)(40,448)(53,689)6,973
Comprehensive income (loss):8,027(28,457)(17,750)(40,448)(53,689)6,973
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     105(72)
Comprehensive income (loss), net of tax, attributable to parent:8,027(28,457)(17,750)(40,448)(53,584)6,901

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: